President Trump can’t stop US coal plants from retiring
More U.S. coal-fired power plants were shut in President Donald Trump's first two years than were retired in the whole of Barack Obama's first term, despite the Republican's efforts to prop up the industry to keep a campaign promise to coal-mining states.
U.S. Crude Oil Inventories Rise by 0.92M Barrels Last Week: EIA...
U.S. Crude Oil Inventories Rise by 0.92M Barrels Last Week: EIA
Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access...
Illumina, Inc. (NASDAQ: ILMN) and Pacific Biosciences (NASDAQ:PACB) today announced they have signed an agreement for Illumina to acquire Pacific Bios
The Cannabis Industry Is Scaling With The Help Of New Technologies
Cannabis is bloomig, and blockchain just might be responsible for some of it.
West Kirkland Reports That Permitting at Hasbrouck Gold Project, Nevada on...
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
Coal mining jobs are holding steady under Trump’s watch
President Donald Trump's vow to revive the coal industry may not have come to pass, but miners have at least halted the plunge in employment.
The politics of hard-rock mining
America needs a new political discourse on hard-rock mining. The time is here to take steps to increase production in Colorado and throughout the American West.
Marlboro maker in takeover talks with cannabis firm Cronos | Business...
Canadian marijuana producer’s shares rise amid hopes of deal with Altria
Source: www.theguardian.com
The maker of Marlboro cigarettes otherwise known as Altria is in talks of...
Hecla Mining Reports Drilling Successes at Casa Berardi, San Sebastian,Greens Creek...
Hecla Mining Reports Drilling Successes at Casa Berardi, San Sebastian,Greens Creek and Nevada Junior Mining NetworkCOEUR D'ALENE, Idaho--(BUSINESS WIRE)--Hecla Mining Company (NYSE:HL) today provided an update on its drilling programs during the first quarter.
MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of...
Source: globenewswire.com
MacroGenics Inc. has announced positive results from SOPHIA, a Phase 3 clinical study of margetuximab in HER2-positive metastatic breast cancer patients. Margetuximab is...


















